MARKER THERAPEUTICS, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-51.0% -$1M
$1M
R&D↓-57.9% -$3M
$2M
D&A
—
Operating Income↑+11.0% +$263K
$-2M
EBITDA↑+11.0% +$263K
$-2M
Interest Income↑+124.6% +$92K
$166K
Tax Provision
—
Net Income↑+13.4% +$310K
$-2M
Operating Margin↓-48.7pts
-173.3%
Net Margin↓-42.3pts
-162.1%
ETR (Continuing Operations)↑+0.5pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.6pts
0.1%
Operating Lease Cost
—
Revenue YoY Variation↓-164.1pts
-51.0%
Income YoY Variation↓-14.0pts
11.0%
Revenue QoQ Variation↓-27.4pts
-10.5%
Income QoQ Variation↑+53.8pts
49.9%